| 000 | 01583 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516145019.0 | ||
| 264 | 0 | _c20131022 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1791-7549 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Wei-Hsun | |
| 245 | 0 | 0 |
_aSimultaneous imaging of temporal changes of NF-κB activity and viable tumor cells in Huh7/NF-κB-tk-luc2/rfp tumor-bearing mice. _h[electronic resource] |
| 260 |
_bIn vivo (Athens, Greece) _c |
||
| 300 |
_a339-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGenes, Reporter |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMolecular Imaging _xmethods |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aChiang, I-Tsang | |
| 700 | 1 | _aLiu, Yu-Chang | |
| 700 | 1 | _aHsu, Fei-Ting | |
| 700 | 1 | _aChen, Hong-Wen | |
| 700 | 1 | _aChen, Chuan-Lin | |
| 700 | 1 | _aLee, Yi-Jang | |
| 700 | 1 | _aLin, Wuu-Jyh | |
| 700 | 1 | _aHwang, Jeng-Jong | |
| 773 | 0 |
_tIn vivo (Athens, Greece) _gvol. 27 _gno. 3 _gp. 339-50 |
|
| 999 |
_c22689239 _d22689239 |
||